Carregant...
Cytokine Use And Survival In The First-Line Treatment Of Ovarian Cancer: A Gynecologic Oncology Group Study
BACKGROUND: Granulocyte colony stimulating factor (G-CSF) and erythropoietin stimulating agents (ESA) may be used to support patients during chemotherapy. We assessed whether G-CSF or ESA were associated with progression or death in patients with ovarian cancer. METHODS: Patients with ovarian cancer...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2012
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3496007/ https://ncbi.nlm.nih.gov/pubmed/23000389 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2012.09.002 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|